Worldwide Clinical Trials
Dr. Robert Krzesz has a strong background in clinical operations, with a focus on CNS and oncology. Dr. Robert has held various senior management positions at Worldwide Clinical Trials, including the role of Senior Manager Clinical Operations - Franchise Lead, CNS. Dr. Robert also served as the Director of Clinical Operations at BioNTech SE. Prior to these roles, Dr. Krzesz gained experience as a Clinical Operations Manager, Lead CRA, and Lead/Senior CRA at Worldwide Clinical Trials. Dr. Robert also worked as a Clinical Scientist at Grünenthal, where they were responsible for study team lead and clinical trial setup. Dr. Krzesz started their career as a Scientist at various academic institutions, including the University of Heidelberg, University of Göttingen, and Jagiellonian University, where they conducted scientific projects and completed their Ph.D. dissertation.
Dr. Robert Krzesz obtained their final secondary-school examinations from VIII LO in 1987. Dr. Robert then pursued a Master of Science Degree in Molecular Biology at Jagiellonian University, Cracow, Department of Molecular Biology from 1987 to 1994. Subsequently, they attained a Doctor of Natural Science (PhD) Degree in Medical Molecular Biology from Collegium Medicum Jagiellonian University, Cracow between 1999 and 2001.
This person is not in any teams
This person is not in any offices
Worldwide Clinical Trials
10 followers
About Worldwide Clinical Trials Worldwide Clinical Trials is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new treatments. Our capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by our team members who bring their expertise and a collaborative, personalized approach to each clinical program. Anchored in our company’s scientific heritage, our dedicated therapeutic focus on cardiovascular, metabolic, neuroscience, oncology, and rare diseases, is applied to develop flexible plans and solve problems quickly for our customers. Our talented team of 3,000+ professionals spans 60+ countries, and embraces a culture of diversity, equity, inclusion, and belonging (DEI&B). We are united in cause with our customers to improve the lives of patients through new, innovative therapies. For more information on Worldwide, visit www.Worldwide.com.